Creative Medical Technology Holdings Inc reports results for the quarter ended December 31 - Earnings Summary

• Creative Medical Technology Holdings Inc CELZ.OQ reported a quarterly adjusted loss of $1.12​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-1.19. The lone analyst forecast for the quarter was for a loss of 63 cents per share.

• Revenue held steady 0% to $3.00 thousand from a year ago; analysts expected zero.

• Creative Medical Technology Holdings Inc's reported EPS for the quarter was a loss of $1.12​.

• The company reported a quarterly loss of $1.85 million.

• Creative Medical Technology Holdings Inc shares had risen by 31.2% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Creative Medical Technology Holdings Inc is $30.00

This summary was machine generated from LSEG data March 20 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)